创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Research Progress of Mesenchymal Stem Cells for Graft-versus-Host Disease
WANG Yuyan, DONG Tengyun, FENG Shan, WANG Huafang
2023, 47(1): 6-15. DOI: 10.20053/j.issn1001-5094.2023.01.002
Abstract PDF
Progress of Research on the Application of Radionuclide Drug in Tumor Cell Therapy
JIANG Yanjun, LI Xiaoyang, HONG Hao
2023, 47(1): 16-34. DOI: 10.20053/j.issn1001-5094.2023.01.003
Abstract PDF
Application of Treg Cell Immunotherapy in the Treatment of Autoimmune Diseases and Transplantation Immunity
ZHANG Wenle, YU Yimeng, LEI Yi, DAI Xueyu, LI Bin
2023, 47(1): 35-42. DOI: 10.20053/j.issn1001-5094.2023.01.004
Abstract PDF
Innovation Strategies and Research Progress of Nature Killer Cell Immunotherapy
ZHANG Hua, DU Wei, QIU Lugui, ZHANG Yu
2023, 47(1): 43-55. DOI: 10.20053/j.issn1001-5094.2023.01.005
Abstract PDF
Metabolic Regulation and Intervention Strategies of Tumor Infiltrating T Cells
SI Yaxuan, YANG Yong
2023, 47(1): 56-65. DOI: 10.20053/j.issn1001-5094.2023.01.006
Abstract PDF
Advances in Research on CELMoDs IKZF1/3 Degraders
WU Xiong, JIAO Yu, LYU Shiming, CHEN Yadong, MEI Desheng
2023, 47(1): 66-74. DOI: 10.20053/j.issn1001-5094.2023.01.007
Abstract PDF
Application of Complement C5 Inhibitor in Disease Treatment Based on Paroxysmal Nocturnal Hemoglobinuria Drug Target
SUN Qingyang, LI Wenlei, LI Jian, XU Hanmei
2023, 47(1): 75-附页4. DOI: 10.20053/j.issn1001-5094.2023.01.008
Abstract PDF